 |
 |
 |
 |
 |
 |
 |
 |
 |
|
| |
Breakout Webcasts |
|
|
| |
 |
Morning Session (before break) 
|
|
|
| |
 |
Morning Session (after break) 
|
|
|
| |
 |
Afternoon Session (before break) 
|
|
|
| |
 |
Afternoon Session (after break) 
|
|
|
| |
 |
Morning Session (before break) 
|
|
|
| |
 |
Morning Session (after break) 
|
|
|
| |
 |
Afternoon Session (before break) 
|
|
|
| |
Presentation Materials for June 15th |
|
|
| |
 |
Overview of the Regulatory Science Initiative and Genetic Testing Registry  
Kathy Hudson, Ph.D.
Chief of Staff
National Institutes of Health
|
|
|
| |
 |
ONC and HITECH: An Update 
David R. Hunt, MD, FACS
Medical Director, Office of Provider Adoption & Support
Office of the National Coordinator for Health IT
|
|
|
| |
 |
CDC Guidelines for Good Laboratory Practices in Genetic Testing 
Bin Chen, PhD, FACMG
Office of Surveillance, Epidemiology, and Laboratory Services
Centers for Disease Control and Prevention (CDC)
Atlanta, GA
|
|
|
| |
 |
Whole-Genome Sequencing-Implications for Clinical Care 
Charis Eng, MD, PhD, FACP
Session Co-Chair
|
|
|
| |
 |
Affordable Whole-Genome Sequencing (WGS) 
Paul Billings, M.D., Ph.D.
SACGHS Members
|
|
|
| |
 |
Overview of WGS 
Dietrich A,. Stephan,PhD
President and CEO
Complete Genomics
|
|
|
| |
 |
Implications of Affordable Whole Genome Sequencing: Quality and Management of WGS Data 
Clifford A. Reid, Ph.D.
President and CEO, Complete genomics
|
|
|
| |
 |
Preparing and Managing Whole Genome Sequence Data for the Clinical Setting 
Martin G. Reese,PhD
Co-Founder, President and CEO
Omicia
|
|
|
| |
 |
WGS Data and Clinical Utility 
W. Gregory Feero, M.D., Ph.D.
Faculty, Maine-Dartmouth Family
Practice Residency Program, Augusta, ME
Special Advisor to the Director for Genomic Medicine NHGRI, NIH
|
|
|
| |
 |
Impact of Whole Genome Sequencing on the Practice of Health Care 
Emily Edelman, MS, CGC
National Coalition for Health Professional Education in Genetics
|
|
|
| |
 |
Ethical, Legal, and Social Issues of WGS 
Richard R. Sharp, Ph.D.
Director, Bioethics Research
Cleveland Clinic
|
|
|
| |
 |
Economic Value of Whole Genome Sequencing 
Steven Teutsch, MD, MPH
Chief Science Officer
Los Angeles County Dept of Public Health
|
|
|
| |
Presentation Materials for June 16th |
|
|
| |
 |
FDA Updates 
Elizabeth Mansfield, Ph.D.
Office of In Vitro Diagnostic Device Evaluation and Safety
Center for Devices and Radiological Health, FDA
|
|
|
| |
 |
SACGHS Session on Genomic Data Sharing 
Charmaine Royal, Ph.D.
Secretary's Advisory Committee on Genetics, Health, and Society
|
|
|
| |
 |
Committee Report on the Retention and Use of Residual Dried Blood Spot Specimens After Newborn Screening 
R. Rodney Howell, M.D.
Chair, Secretary's Advisory Committee on Heritable Disorders in Newborns and Children
|
|
|
| |
 |
Carrier Screening 
Sara Copeland, MD
Workgroup on Carrier Screening
Secretary's Advisory Committee on Heritable Disorders in Newborns and Children
|
|
|
| |
 |
Challenges and Opportunities in Using Newborn Screening Samples for Translational Research:A Workshop of the Institute of Medicine 
Adam Berger, Ph.D.
Project Director
Roundtable on Translating Genomic-Based Research for Health
|
|
|
| |
 |
SACGHS Review of SACHDNC Draft Briefing Paper on Retention and Use of Residual Dried Blood Spot Specimens After Newborn Screening 
Janice V. Bach, M.S., CGC
SACGHS Steering Group Leader
|
|